您现在的位置是:DermaSensor: World's first AI >>正文
DermaSensor: World's first AI
上海品茶网 - 夜上海最新论坛社区 - 上海千花论坛49人已围观
简介By subscribing, you agree to our Terms of Use and Policies You may unsubscribe at any time.In a rece...
By subscribing, you agree to our Terms of Use and Policies You may unsubscribe at any time.
In a recent pioneering development, the US Food and Drug Administration (FDA) granted marketing authorization to the DermaSensor, an artificial intelligence-powered hand-held device designed for the early detection of skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma.
Predominantly tailored for use by primary care physicians, DermaSensor uses elastic scattering spectroscopy to look at cellular and subcellular characteristics of suspicious skin lesions.
This breakthrough technology is aimed at empowering healthcare providers with an innovative tool for more accurate and timely diagnosis.
Intersection of artificial intelligence and healthcare
The device can collect five spectral recordings from a lesion in a single scan. Subsequently, an algorithm, fine-tuned through the scrutiny of over 20,000 scans, evaluates the data.
See Also Related- Scientists use AI to predict when cancer cells will resist chemotherapy
- A new study reduces melanoma skin cancer death risk by 44%
The outcome is then presented to the user, indicating either "Investigate Further" or "Monitor." The former suggests that the patient should be referred to a dermatologist, while the latter implies no immediate need for specialist intervention.
“We are entering the golden age of predictive and generative artificial intelligence in healthcare, and these capabilities are being paired with novel types of technology, like spectroscopy and genetic sequencing, to optimize disease detection and care,” said Cody Simmons, co-founder and CEO of DermaSensor.
While dozens of companies have attempted to address this problem in recent decades, we are honored to be the first device cleared by the FDA that provides PCPs with an automated tool for evaluation of suspicious lesions,” added Simmons.
Encouraging values
A key factor in the FDA's decision was the performance of DermaSensor in a study published in November 2023 in JAAD International.
The study reported an observed sensitivity of 95.5 percent for detecting melanomas and a specificity of 32.5 percent. Despite the lower specificity, the positive and negative predictive values were encouraging at 16.0 percent and 98.1 percent, respectively.
In earlier clinical studies as well, DermaSensor exhibited a sensitivity of 94 percent for accurately classifying 338 high-risk lesions and a specificity of 23 percent for correctly identifying 1,681 low-risk lesions.
Across ten study sites, the device demonstrated a 96% sensitivity for melanoma detection and a 91 percent sensitivity for high-risk melanocytic lesions.
“Achieving this medical milestone is a testament to the 12 years and tens of millions of dollars our company has invested in research and development to bring this powerful technology to market,” said Dr. Maurice Ferre, co-founder and chairman of DermaSensor.
The introductory pricing for the device for healthcare providers is $199 per month for up to five patients, and for those opting for unlimited usage, the price is $399 per month.
Tags:
转载:欢迎各位朋友分享到网络,但转载请说明文章出处“上海品茶网 - 夜上海最新论坛社区 - 上海千花论坛”。http://www.jz08.com.cn/news/325646.html
相关文章
Here are the best places to buy Dogecoin
DermaSensor: World's first AIDogecoin is gaining rapidly after Elon Musk announced he would begin accepting it as payment for som...
阅读更多
Get Thee to Totality: Nashville
DermaSensor: World's first AIOn April 8, 2024, the moon’s shadow will completely cover the sun for around three and a half minute...
阅读更多
US Air Force performs final test on HAWC hypersonic missile
DermaSensor: World's first AIBy subscribing, you agree to our Terms of Use and Policies You may unsubscribe at any time.DARPA and...
阅读更多
热门文章
- Auckland man charged with money laundering cryptocurrencies
- SafePal soaring today, up almost 18%: Where to buy SafePal
- Tezos price turns bullish as France selects blockchain for stablecoin experiment
- MDT up 56% today: here’s where to buy MeasurableDataToken
- IRS To Reward Whoever Can Track Monero Transactions
- Iggy Azalea & Charli XCX Pay Homage to Clueless in “Fancy” Music Video
最新文章
Internet Killed the Video Star
Tron foundation’s founder Justin Sun is leaving – will this affect pricing?
Cardano slumping, CRO displaces SHIB, Zoom shares crash
3 Best undervalued altcoins on Solana to buy in 2022
3 tokens watch as crypto eyes bounce: PYTH, TIA, MMTR
OKX and HashKey Group eye partnership to boost crypto innovation in Hong Kong